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Abstract: Superparamagnetic iron oxide nanoparticles
(SPION) are used for an increasing range of biomedical appli-
cations, from imaging to mechanical actuation of cells and
tissue. The aim of this study was to investigate the loading
of smooth muscle cells (SMC) with SPION and to explore
what effect this has on the phenotype of the cells. Adherent
human SMC were loaded with 17 pg of unconjugated, neg-
atively charged, 50 nm SPION. Clusters of the internalized
SPION particles were held in discrete cytoplasmic vesicles.
Internalized SPION did not cause any change in cell morphol-
ogy, proliferation, metabolic activity, or staining pattern of
actin and calponin, two of the muscle contractile proteins
involved in force generation. However, internalized SPION
inhibited the increased gene expression of actin and calponin
normally observed when cells are incubated under differen-
tiation conditions. The observed change in the control of
gene expression of muscle contractile apparatus by SPION
has not previously been described. This finding could offer
novel approaches for regulating the phenotype of SMC and
warrants further investigation. VC 2016 The Authors Journal of
Biomedical Materials Research Part A Published by Wiley Periodicals,
Inc. J Biomed Mater Res Part A: 104A: 2412–2419, 2016.
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INTRODUCTION
Muscle insufﬁciency is a signiﬁcant clinical challenge for a
wide range of acquired and congenital clinical conditions.
Improved therapies are sought that will increase muscle
mass and restore organ function. Smooth muscle poses a
speciﬁc set of challenges due to the lack of accessible sites
suitable for harvesting autologous donor cells for regenera-
tive medicine purposes. Smooth muscle cells (SMC) can
switch between a differentiated “contractile” phenotype and
a “proliferative” or “synthetic” phenotype.1–4 The possibility
of harnessing this phenotypic plasticity to form new tissues
is an attractive strategy for the ex vivo bioengineering of
various tissues, including arteries and sphincter muscle.5,6
Shifting the proliferative SMC toward a contractile pheno-
type can be achieved via intra- or extracellular stimuli
including soluble signalling factors, extracellular matrices,
and mechanical stimulation. The resulting phenotypic state
is characterized by the expression pattern of protein
markers, proliferative capacity, and cell morphology.7,8
SMC in the vasculature are subjected to continuous
cyclic mechanical loading and the biological effects of this
form of stimulation have been investigated extensively.9
Mechanical stimulation to control muscle phenotype has
been achieved in vitro by culturing cells in a mechanically
active environment, for example the FlexcellVR Tension Sys-
tem, a computer-regulated bioreactor that uses vacuum
pressure to apply cyclic or static strain to cells cultured on
ﬂexible-bottomed Bioﬂex culture plates. Using this system,
deformation of the cytoskeleton has been shown to regulate
cellular events and act as a potent mitogen, inducing prolif-
eration of myoblasts and SMC in vitro.9,10
Iron oxide nanoparticles are being increasingly used for
a variety of biomedical applications. This includes imaging,
targeted delivery of active pharmaceutical ingredients, tissue
engineering, and destruction of tumour cells via hyperther-
mia.11 To date, their effect on smooth muscle phenotype has
not been investigated. We have previously shown that nega-
tively charged superparamagnetic iron oxide nanoparticles
(SPION) are endocytosed by cells and held in discrete
vesicles in the cytoplasm.12 Based on this observation we
hypothesize that endocytosed clusters of SPION could have
an effect on regulating cellular events, such as cell prolifera-
tion, differentiation, or morphogenesis. This could be partic-
ularly valuable for tissues such as muscle, where individual
cells could be magnetically targeted to stimulate an increase
in muscle cell growth and/or control of cell phenotype.
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In the current study, we explore the concept of regulat-
ing cellular phenotype via loading of intracellular SPION
using 50 nm negatively charged SPION.
MATERIALS AND METHODS
Cell culture
Primary cultures of human rectal smooth cells (HRSMC)
were obtained from ScienCellTM (Catalogue Number: 2980).
Cells were cultured in either proliferation medium consist-
ing of Minimum Essential Medium Eagle (Sigma Aldrich,
UK) supplemented with 10% foetal bovine serum (FBS)
(Life Technologies Ltd, UK), 13 non-essential amino acids
(NEAA), 2 mM glutamine, 50 U/mL penicillin, and 50 mg/
mL streptomycin (Sigma Aldrich, UK), or differentiation
medium consisting of Dulbecco’s Modiﬁed Eagle Medium
(Sigma Aldrich, UK) supplemented with 13 NEAA, 2 mM
glutamine, 50 U/mL penicillin, 50 mg/mL streptomycin, and
2 ng/mL transforming growth factor (TGF)-b (PeproTech EC
Ltd, UK).
Loading of SPION in HRSMC
Unconjugated, negatively charged SPION (ﬂuidMAG-UC/A;
Chemicell GmbH, Berlin, Germany) was used for all experi-
ments. This consisted of an aqueous dispersion with a stock
concentration of 25 mg/mL and particle density of 1.3 3
1016 particles/g. The SPION were uncoated and had an ani-
onic surface charge. The particle size, determined by the
manufacturer using photon correlation spectroscopy, was
50 nm, which corresponds to the hydrodynamic diameter of
the multi-core domain structures consisting of a cluster of
several 8–15 nm single domain iron oxide crystals and asso-
ciated hydrogen-bonded shell of water molecules.
HRSMC grown in 75-cm2 tissue culture ﬂasks were incu-
bated at 378C and 5% CO2 in proliferation medium supple-
mented with SPION at a ﬁnal concentration of 250 mg/mL.
After 24 h, the cells were washed ﬁve times with 10 mL of
phosphate buffered saline (PBS), were detached by trypsini-
zation, and re-seeded for a further 24 h. Then the culture
medium was replaced with proliferation or differentiation
medium for 7 days.
Quantiﬁcation of SPION in HRSMC
Cells incubated with SPION were washed and detached by
trypsinization followed by washing and centrifugation. After
performing a cell count, cells were centrifuged again and
the pellet lyophilized overnight. The amount of SPION
loaded into the cells was measured by superconducting
quantum interference device (SQUID) magnetometry. A
Quantum Design SQUID-VSM magnetometer (Quantum
Design Inc, San Diego, CA) was used to apply a magnetic
ﬁeld to each sample in the range of 7 T to 27 T at a tem-
perature of 300 K. A background diamagnetic component
from the sample holder and diamagnetic compounds in the
sample was determined from the linear regions of the graph
(at ﬁelds above 13T and below 23T) and removed. The
saturation magnetic moment due to the SPION in the sam-
ples thus obtained was used to estimate the SPION mass
per cell, assuming a saturation magnetization for the SPION
of 73 emu/g. This was then plotted against the concentra-
tion of SPION in the incubation medium.
Ultrastructural localization of SPION
Transmission electron microscopy (TEM) was used to deter-
mine the cellular localization of SPION in HRSMC attached
to the base of the tissue culture plates. After loading and
washing, samples were ﬁxed in 2% paraf-
ormaldehyde1 2.5% gluteraldehyde in 0.1M cacodylate
buffer and subsequently post-ﬁxed in a solution of phos-
phate buffered 1% osmium tetroxide for 30 min to avoid
any contrast masking on the SPION. After progressive dehy-
dration series in ethanol, the base of the plates were scored
with a scalpel and the monolayer of cells were detached
from the base of the plate by adding propylene oxide. The
cell sheets were placed in two further changes of propylene
oxide to remove residual tissue culture plastic from the cells
and to act as a transition solvent before the embedding
stage. In order to enhance the inﬁltration of samples with
an Araldite CY212 resin (Agar Scientiﬁc), two further stages
of 90 min each in mixtures of 1:3 and 1:1 resin/propylene
oxide at room temperature were allowed, after which the
cells were embedded in pure Araldite medium at 608C for
36 h. The resulting blocks were thin sectioned in an ultra-
microtome and directly collected onto copper grids for
examination under a JEOL JEM 1200EX TEM operating at
80 kV.
Scanning electron microscopy (SEM) was used to inves-
tigate surface features of HRSMC incubated with SPION.
Cells were ﬁxed and dehydrated, as described above before
being mounted on an aluminium stub using silver paint.
Samples were coated with gold/palladium before examina-
tion under a JSM-7500F scanning electron microscope
(JEOL, USA).
Immunocytochemistry
The expression of smooth muscle contractile proteins using
monoclonal antibodies speciﬁc to a-smooth muscle actin
(clone 1A4, 1:1000; Sigma), calponin (clone hCP, 1:1000;
Sigma), caldesmon (clone hHCD, 1:500; Sigma), and myosin
heavy chain (clone hSM-V, 1:500; Sigma) was investigated
by immunocytochemistry. HRSMC were seeded in 35-mm
FluorodishTM cell culture dishes (World Precision Instru-
ments, USA) and incubated as speciﬁed for each experiment.
The medium was removed and cells were ﬁxed in 4% form-
aldehyde in PBS for 10 min at room temperature. After
washing in PBS, cells were incubated in 3% BSA1 0.1% Tri-
ton in PBS for 1 h at room temperature to block non-
speciﬁc protein binding and to permeabilize the cells. The
primary antibody diluted in PBS was added to each dish
and incubated for 1 h at room temperature, followed by
washing and incubation for 1 h with anti-mouse IgG FITC
conjugated secondary antibody (F9006, 1:500; Sigma). The
dishes were mounted with glass coverslips using mounting
medium containing DAPI (VectashieldVR Mounting Medium
with DAPI, Vector Laboratories Ltd, UK). Images were
acquired using a ﬂuorescence microscope (BX51 Olympus,
GX Optical, UK).
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Expression of smooth muscle cell genes
RNA was extracted from cells using the RNeasy mini kit
(Qiagen, UK), following manufacturer’s instructions. The
amount and quality of RNA in each sample was quantiﬁed
using a TA NanoDrop ND-1000 spectrophotometer (Thermo-
scientiﬁc, UK). Complementary DNA (cDNA) libraries were
prepared using a cDNA synthesis kit (Applied Biosystems,
UK). Real time polymer chain reaction (PCR) was used to
quantify the amount of cDNA present in the sample. The
expressions of actin (ACTA2), myosin heavy chain (MYH11),
caldesmon CALD1, and calponnin (CNN1) were investigated,
along with GAPDH as the house keeping gene, using com-
mercially available primers (Applied Biosystems, UK). The
PCR reaction mixtures were transferred to a 384-well plate
(MicroAmpTM, Applied Biosystems) and sealed with a ﬁlm
lid. The plate was centrifuged and placed in a LightCycler
480 (Roche, UK) for the real time PCR reaction to occur.
The sample reading was normalized according to the house-
keeping gene GAPDH.
Cell proliferation and metabolic assays
The proliferation of HRSMC was measured using a Colori-
metric BrdU ELISA Assay (Roche, UK) following the manu-
facturer’s instructions. The metabolic activity of HRSMC
cells was measured using the CellTiter 96 Aqueous Non-
Radioactive Cell Proliferation Assay (Promega, UK).
Data analysis
Data analysis was performed using GraphPad Prism version
5.00 for Windows, (GraphPad Software, San Diego, CA). All
experiments were repeated in replicates of four, except for
the PCR analysis which was repeated in triplicate. Statistical
signiﬁcance was tested using one-way ANOVA and Tukey
test post hoc analysis. Values were considered signiﬁcant
when p< 0.05.
RESULTS
Loading HRSMC with SPION
Following incubation of HRSMC in proliferation medium
containing 250 lg/mL SPION for 24 h and subsequent
washing stages to remove unbound particles, SPION clusters
associated with the cells were clearly visible using light
microscopy [Figure 1(a)]. SPION loaded cells retained the
spindle morphology similar to that seen with control cells.
TEM of the HRSMC incubated with SPION revealed the par-
ticles were held in vesicles inside the cytoplasm [Figure
1(b)]. SEM indicated SPION clusters on the cell surface
despite extensive washing stages, suggesting the particles
were tethered to the surface [Figure 1(c)].
Effect of switching between proliferation and
differentiation medium following loading HRSMC with
SPION
SQUID magnetometry was used to quantify the amount of
SPION loading in HRSMC after incubation in proliferation
medium for 24 h. The average remaining amount of SPION
per cell after 7 days incubation in proliferation medium was
reduced compared with the average amount per cell
FIGURE 1. (a) Light microscopy of HRSMC following incubation with
culture medium containing 250 mg/mL SPION for 24 h. SPION is visible
as brown material in the cells. (b) Transmission electron microscopy of
HRSMC following incubation with culture medium containing 250 mg/
mL SPION for 24 h. SPION particles are internalized in vesicles (arrows)
inside the cells. (c) Scanning electron microscopy of SPION clusters
(pseudo colored brown) attached to the surface of HRSMC following
incubation with culture medium containing 250 mg/mL SPION for 24 h.
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measured after 24 h incubation (Figure 2). The amount was
also reduced compared with the average amount of SPION
measured in cells incubated in differentiation medium for
7 days. This coincided with an increase in cell number after
7 days incubation in proliferation and no change in cell num-
ber for cells incubated in differentiation medium for 7 days.
The aspect ratio increased from 4.466 0.44 for cells
incubated in proliferation medium to 9.2360.71 for cells
FIGURE 2. (a) SQUID measurement of the amount of iron loaded per
cell after incubation of HRSMC in culture medium containing 250 mg/
mL SPION for 24 h (day 1 PRO1SPION), or incubation for a further 7
days in proliferation medium (day 7 PRO1SPION) or differentiation
medium (day 7 DIFF1SPION). The amount of iron loaded per cell
was significantly lower after 7 days incubation in proliferation
medium compared with amount measured at day 1. (b) Cell counts of
HRSMC after incubation in culture medium containing 250 mg/mL
SPION for 24 h (day 1 PRO1SPION), or incubation for a further 7
days in proliferation medium (day 7 PRO1SPION) or differentiation
medium (day 7 DIFF1SPION). (***p< 0.001).
FIGURE 3. The effect of switching HRSMC from incubation in prolifer-
ation medium to differentiation medium for 7 days. (a) Cell aspect
ratio, (b) BrdU ELISA cell proliferation assay, and (c) cell metabolic
assay measured using the CellTiter 96 aqueous non-radioactive cell
proliferation assay. (*p< 0.05, ***p< 0.001).
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incubated in differentiation medium (p<0.001). Loading
cells with SPION also caused a small increase in the aspect
ratio to 6.546 0.64 for cells incubated in proliferation
medium and decreased to 7.776 0.58 for cells incubated in
differentiation medium [Figure 3(a)].
Incubation of HRSMC in differentiation medium caused a
signiﬁcant reduction in cell proliferation compared with cells
incubated in proliferation for 7 days [Figure 3(b)]. However,
loading cells with SPION before incubation in proliferation or
differentiation medium did not cause any further change for
either group. An identical pattern was observed with the
measurements of cell metabolic activity [Figure 3(c)].
The effect that loading cells with SPION had on the dif-
ferentiation of HRSMC toward a contractile phenotype was
FIGURE 4. Fluorescence microscopy of HRSMC stained for the contractile proteins actin and calponin. (a) After incubation in proliferation
medium6 250 mg/mL SPION for 24 h followed by incubation in proliferation medium for 7 days. (b) After incubation in proliferation medium6
250 mg/mL SPION for 24 h followed by incubation in differentiation medium for 7 days.
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investigated by switching from proliferation to differentia-
tion medium. Cells were initially incubated in proliferation
medium containing 250 lg/mL SPION for 24 h, followed by
washing stages to remove unbound particles. At this stage,
the cells were incubated with either proliferation medium
or differentiation medium for a further 7 days. Strong actin
and calponin staining was visible in cells incubated in pro-
liferation medium. The staining was mainly diffuse and dis-
tributed throughout the cytoplasm. The loading of SPION
did not change this staining pattern (Figure 4). The staining
pattern of actin and calponin changed following incubation
in differentiation medium for 7 days. Staining remained
strong for both proteins but exhibited a ﬁlamentous distri-
bution. No staining was visible for caldesmon or myosin
heavy chain for any of the groups.
The relative gene expression of actin and calponin were
both increased fourfold following incubation in differentia-
tion medium for 7 days compared with cells incubated in
proliferation medium for the same period of time (Figure
5). Incubation of HRSMC with SPION for 24 h before incuba-
tion in differentiation medium for 7 days inhibited the
increase in actin and calponin gene expression. Loading
HRSMC with SPION followed by incubation in proliferation
medium for 7 days produced no change in the relative gene
expression. No increase in the expression of caldesmon or
myosin heavy chain was measured for any of the groups.
DISCUSSION
The aim of the current study was to investigate what effect
the loading of SMC with SPION would have on the cell phe-
notype. Incubation of HRSMC with negatively charged,
uncoated SPION added to the tissue culture medium for
24 h led to the loading of cells with magnetic material. Mag-
netometry data indicate SPION loading by HRSMC was not
signiﬁcantly increased by increasing the concentration of
SPION in the culture medium (data not shown). Following
washing stages to remove unbound SPION from the cells,
TEM indicated much of the SPION was internalized and
held in endosome-like structures. SEM of the cell surface
indicated clusters of SPION also remained tethered to the
cell. It is possible these clusters could be in the process of
undergoing either endocytosis or exocytosis. TEM revealed
internalized SPION was localized to vesicles that had been
transported into the cytoplasm.
Previous studies have performed detailed investigations
of the uptake of SPION by cells.13,14 Use of chemical inhibi-
tors in these studies indicates uptake via endocytosis of
SPION occurs via a scavenger receptor pathway independ-
ent of dynamin, caveolae, and clathrin-coated pit. Although
these studies were conducted with different SPION and cell
types, they provide an indication of the type of speciﬁc
uptake pathways likely to be occurring in the current study.
Appropriate spatial and temporal control of cellular
apparatus at the gene and protein level is essential for SMC
to retain the correct phenotype according to the functional
requirements of their native tissue. In tissues such as the
aorta there is a mixture of SMC with proliferative and
FIGURE 5. Gene expression of the actin, calponin, caldesmon, and
myosin heavy chain in HRSMC after incubation in proliferation
medium6 250 mg/mL SPION for 24 h followed by incubation in prolif-
eration medium or differentiation medium for 7 days. Quantification
is relative to the expression of each marker following incubation in
proliferation medium alone for 7 days, which was normalized to a
value of 1. (*p< 0.05; **p< 0.01).
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contractile phenotypes.15 This differs from the in vitro
expansion of SMC in culture, where there is a predominance
of cells in a proliferative phenotype and suppression of pro-
tein expression associated with the contractile cell pheno-
type. The relative expression of contractile apparatus, such
as a-smooth muscle actin, calponin, caldesmon, and myosin
heavy chains can be used to characterize SMC cells along
the proliferative-contractile continuum.16,17 a-Smooth mus-
cle actin and calponin are considered to be early and inter-
mediate markers of smooth muscle cell differentiation,
whereas caldesmon and myosin heavy chains are intermedi-
ate to late markers of differentiation.18
HRSMC in the current study were shifted toward a more
contractile, less proliferative phenotype by incubating cells
in FCS depleted culture medium supplemented with TGF-
b1. HRSMC initially incubated in proliferation medium
exhibited diffuse cytoplasmic staining of a-smooth muscle
actin and calponin. When the cells were switched to differ-
entiation medium for 7 days, the localization of aSMA and
calponin staining became ﬁlamentous. Similarly, the switch
to differentiation medium resulted in a fourfold increase in
the gene expression of a-smooth muscle actin and calponin.
These observations are in keeping with previous studies
that have shown TGFb1 induces the expression and organi-
zation of contractile apparatus in SMC.19–23 Further evi-
dence of HRSMC differentiation toward a contractile, less
proliferative phenotype was the decrease in cell prolifera-
tion compared with cells incubated for the same length of
time in proliferation medium, and an increase in the cell
aspect ratio. Interestingly, the average amount of SPION per
cell decreased after 7 days incubation in proliferation
medium compared with the starting amount, whereas the
amount remained unchanged for cells incubated in differen-
tiation medium. This is likely to result from the internalized
SPION being divided amongst progeny as the cells prolifer-
ated. Accordingly, the cells in differentiation medium did
not proliferate, so the average amount of SPION per cell
remained unchanged. Neither caldesmon nor myosin heavy
chain protein was detected in HRSMC incubated in prolifera-
tion or differentiation medium. The reason for this might
relate to their temporal expression and the duration of incu-
bation in differentiation medium performed in the current
experiments.
Incubation of HRSMC in proliferation or differentiation
medium containing SPION did not affect the intensity or
localization of protein staining observed in the cells. How-
ever, loading HRSMC with SPION inhibited the gene expres-
sion of a-smooth muscle actin and calponin when cells
were switched to differentiation medium compared with
unloaded HRSMC. The mechanism underlying the inhibition
of these two genes, both of which are associated with the
shift of SMC from a proliferative to contractile phenotype, is
uncertain at this stage, but could be related to interference
with TGFb1 signaling by inhibition of SMAD genes. SMC dif-
ferentiation via TGF-b1 binding occurs via signalling in the
SMAD pathway, causing inhibition of cell proliferation and
induction of contractile proteins in SMCs.8,20,21,24,25 Gene
expression proﬁling of HeLa cells following incubation with
26 nm magnetite nanoparticles and their internalization
resulted in down-regulation of 68 genes, many of which
were involved in the TGFb signaling pathway.26 Although
the effects of SPION on the regulation of gene expression
are likely to be cell speciﬁc, this evidence implicates inter-
ference of TGFb and SMAD signal transduction. The protein
products of actin and calponin play a role in force genera-
tion and modulation of myosin ATP-ase activity, respec-
tively.27,28 Future studies will focus on the down-stream
events of gene regulation produced by SPION, including
incubation periods that extend beyond 7 days and cell con-
traction studies to provide a more robust indication of SMC
phenotype and to clarify whether these observed effects
result in changes to the functional capacity of HRSMC. In
addition, another line for future study will be to investigate
the possible mechanical effects associated with the SPION
uptake by the cells. It is notable that at about 17 pg, the
measured SPION mass per cell is a sizeable fraction of the
estimated about 30 pg mass of an adherent HRSMC (assum-
ing 5 lm diameter, 1.5 lm thickness, 1 g/cc density), which
might in itself have a signiﬁcant effect on the characteristics
of the contractile phenotype of the cell. It would be very
interesting to explore this further, as a function of the
SPION mass per cell loading.
In conclusion, SPION internalized by HRSMC prevented
the up-regulation of calponin and actin mRNA normally
observed in response to incubation with TGF-b1. This might
offer novel therapeutic opportunities for the use of SPION
in regenerative medicine relating to control of the muscle
phenotypic continuum. It will be important to understand
the consequence of these changes on the function of SMC,
particularly whether this effect is speciﬁc to HRSMC, and
whether similar effects occur to SMC at other stages of the
phenotypic continuum in vitro and in vivo.
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